-

Riverside University Health System to Implement FloPatch by Flosonics, Revolutionizing Precision Fluid Management in Sepsis Care

RIVERSIDE, Calif.--(BUSINESS WIRE)--Riverside University Health System is proud to announce the implementation of FloPatch by Flosonics Medical. As a pioneer in adopting new, ground-breaking medical technology, Riverside is making a significant leap forward in healthcare innovation, particularly in the life-saving area of sepsis management.

"We are excited and proud to be one of the early adopters of this cutting-edge technology, and the timing couldn’t be better as we raise awareness during Sepsis Awareness Month,” said Jaclyn Bond, Director of Nursing at Riverside University Health System.

Share

FloPatch is a revolutionary tool that facilitates real-time precision in IV fluid management in sepsis. This FDA-cleared, wireless, wearable, point-of-care, Doppler ultrasound system empowers clinicians to accurately assess a patient and determine the most appropriate therapeutic intervention.

“FloPatch rapidly provides non-invasive hemodynamic data that help guide the clinician’s management of complex patients. I’m excited to have this tool to incorporate into our sepsis program as well as use it to manage other critically ill patients," said Dr. Korbin Haycock, Co-Sepsis Chair, Ultrasound Director, and Emergency Medicine Physician at Riverside University Health System.

Specifically engineered for quick, reliable assessments, FloPatch adheres to a patient's neck over the carotid artery. It immediately starts capturing real-time blood flow data for each heartbeat. This data is then wirelessly sent to a secure iOS app for healthcare providers, which not only displays real-time Doppler data but also uses advanced analytics to break down each heartbeat into key metrics. Such data enables informed, time-sensitive decisions at the bedside, a level of precision that is indispensable in complex and urgent medical scenarios like sepsis management.

“Timing of assessment and appropriate fluid resuscitation is critical in sepsis. Our code team has seen firsthand how efficient FloPatch is in assessing both responsiveness and tolerance in sepsis and septic shock,” said Jaclyn Bond, Director of Nursing at Riverside University Health System. “We are excited and proud to be one of the early adopters of this cutting-edge technology, and the timing couldn’t be better as we raise awareness during Sepsis Awareness Month.”

Dr. Destry Washburn, Co-Sepsis Chair and Intensivist at Riverside University Health System, concurred: "FloPatch will help us better manage sepsis patients as they triage from the ED to ICU because FloPatch travels with the patient. This will facilitate better communication between our nurses and clinicians as we continue their fluid resuscitation in the hospital, which will lead to more comprehensive care for our patients."

About Riverside University Health System

Riverside University Health System has been a cornerstone in healthcare for Riverside County for over 50 years. With a steadfast commitment to pushing the boundaries of medical science and technology, Riverside continues to set the standard for healthcare excellence in the region.

About Flosonics Medical

Flosonics Medical is a Canadian medical device company engaged in the research and development of innovative ultrasound technology. Founded in 2015, the company’s mission is to improve patient care and the practice of medicine through technology-enabled solutions and ground-breaking clinical research.

For more information, visit www.ruhealth.org and http://www.flosonicsmedical.com.

Contacts

Media
Rachelle Gibson, Senior Marketing Manager, Flosonics Medical
rgibson@flosonicsmedical.com
530-651-3855

Flosonics Medical


Release Summary
Riverside University Health System adopts FloPatch by Flosonics, elevating sepsis care with precision fluid management during Sepsis Awareness Month.
Release Versions

Contacts

Media
Rachelle Gibson, Senior Marketing Manager, Flosonics Medical
rgibson@flosonicsmedical.com
530-651-3855

Social Media Profiles
More News From Flosonics Medical

Sutter Health Hospitals Deploy Wearable Ultrasound Tech to Personalize Fluid Management for Sepsis

SACRAMENTO, Calif. & LOS ANGELES--(BUSINESS WIRE)--Sutter Health, an integrated not-for-profit healthcare system based in Northern California, and Flosonics Medical today announced an expansion of the deployment of FloPatch, the first wireless wearable Doppler ultrasound device, across multiple hospital sites to support more precise and timely intravenous (IV) fluid management. This multisite deployment includes Sutter’s Alta Bates Summit Medical Center, Summit Campus in Oakland and Sutter Sant...

World’s First Wearable Doppler Ultrasound Patch Expands to East Coast to Enhance Patient Safety at The Mount Sinai Hospital

LOS ANGELES--(BUSINESS WIRE)--Flosonics Medical, the leader in wearable ultrasound for critical care, today announced that The Mount Sinai Hospital has adopted FloPatch, the first wireless Doppler ultrasound device, in its surgical and transplant intensive care units. This milestone marks the company’s first East Coast deployment, expanding its U.S. footprint and reinforcing growing demand for real-time, individualized fluid management in ICUs. FloPatch is an FDA-cleared, non-invasive wearable...

Flosonics Medical Secures $7.5 Million CAD Venture Debt from RBCx to Scale Transformative Wearable Ultrasound Technology

SUDBURY, Ontario--(BUSINESS WIRE)--Canadian medical device innovator, Flosonics Medical, has secured $7.5 million CAD in venture debt financing from RBCx. The financing and specialized support will accelerate Flosonics Medical’s mission to improve patient outcomes through non-invasive, data-driven solutions that empower clinicians to make faster, more informed decisions at the bedside. Sepsis is a critical health challenge, affecting over 75,000 patients annually in Canada1 and 1.7 million in t...
Back to Newsroom